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Small Ruminant Lentivirus infections in sheep most commonly present with respira-
tory signs (maedi) and indurative mastitis, while primary neurological signs (visna)
have rarely been reported in Great Britain. Most reports of visna describe signs refer-
able to myelitis, although central signs associated with encephalitis may feature. In this
case, visna was diagnosed in a 4-year-old ewe in a small pedigree sheep flock, recently
imported to GB from northern Europe. Initial clinical findings were of a head tilt,
circling, facial tremors and a unilaterally reduced menace response. These neurologi-
cal signs progressed to include hyperaesthesia, ipsilateral hemiparesis and recumbency.
Flock level infection had recently been diagnosed by serology, and the diagnosis in this
individual case was confirmed by serology and histopathology. The subsequent sale of
animals from the flock through a large national auction and at private sales raises sig-
nificant ethical questions and serves as a reminder of the importance of biosecurity pre-
cautions.
BACKGROUND
Maedi visna (MV) is a chronic, fatal disease of sheep caused
by infection with small ruminant lentivirus (SRLV). Clini-
cal signs most often progress slowly, and, anecdotally, flocks
have often reached seroprevalences of at least 50% before the
disease is identified. However, in the preceding period, sub-
clinical disease is likely to have caused significant economic
losses.1 MV is therefore commonly considered an ‘Iceberg dis-
ease’, where clinical cases represent only a small fraction of
the flock level impact. The accurate and timely identification
of clinical cases is important, especially in flocks that do not
routinely screen for such iceberg diseases. Maedi (lymphofol-
licular pneumonia resulting in dyspnoea) is themost common
presentation of infection with SRLV in sheep; however, there
have been three historic reports of visna (progressive inflam-
matory disease of the central nervous system) in GB.2–4 The
visna presentation was relatively common when MV was first
seen in Iceland5 and has been more recently reported in out-
breaks in Spain.6 It is hypothesised that geographical variation
in the signs seen may represent a combination of variation in
both susceptibility of sheep breeds and virus subtypes.7,8
Over the past 10 years, the number of Premium Sheep and
Goat Health Scheme (PSGHS) member flocks in which SRLV
infection has been identified has been less than 1%, and in that
time the number ofmember flocks has risen from 2500 to 3261
(SRUC, personal communication). However, this is a small
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
© 2021 The Authors. Veterinary Record Case Reports published by John Wiley & Sons Ltd on behalf of British Veterinary Association
fraction of the total number of flocks (approximately 35,000),9
and there have been concerns in the British veterinary and
farming press following high-profile cases that have had
devastating impacts in both commercial and pedigree
flocks.10–17 It is therefore extremely important that farmers
and vets consider the risks of introducingMV into their flocks
through the purchase of replacement animals.
This article describes the diagnosis of a case of visna in a
flock of pedigree sheep recently imported into Great Britain,
provides detailed mapping of the neuropathological lesions
present in this case and discusses the biosecurity risks arising
from the subsequent sale of animals from the flock at a large
UKauction and through private sales. This serves as an impor-
tant reminder of: the variable clinical presentation of MV; the
biosecurity risks presented by bought in replacement animals;
and the ethical challenges veterinary surgeons commonly face
in practice.
The location of the farm, the name of the referring veteri-
nary surgeon and the breed of sheep have been redacted to
maintain the flock owner’s anonymity.
CASE PRESENTATION
A flock of approximately 30 pedigree ewes was imported into
GB in early 2018, following the relocation of their owner from
northern Europe. The owner had intended to establish the
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flock as MV accredited under the PSGHS in order to max-
imise the value of lambs sold as pedigree replacements or
terminal sires. However, at the first qualifying test, an SRLV
seroprevalence of approximately 50%had been identified. The
owner had not noticed signs of clinical disease or reduced
performance in the flock and decided not to immediately
pursue options for elimination or reduction of MV within the
flock.
In July 2018, the referring veterinary surgeon was called to
examine a 4-year-old ewe displaying neurological signs. This
ewe had been seronegative for SRLV on the first qualifying test
(carried out 6 months previously). The ewe had been housed
between arrival in the UK and lambing in April and was fed
silage and compound concentrate feed during that period. She
had lambed twins in April and was then turned out onto low
ground pasture co-grazed with cattle, with some additional
concentrate feeding provided. The lambs were not weaned at
the time of the first clinical examination. There was no recog-
nised problem with ticks on the holding.
INVESTIGATIONS
Differential diagnosis
On clinical examination the ewe exhibited a head tilt and
circling to the right, mild tremors of the muzzle and ears
bilaterally, and a reduced menace response on the left-hand
side (limited response to threatening the eye, despite normal
palpebral and pupillary light reflexes). The ewe was in moder-
ate to lean body condition score (2/5), shewas not pyrexic, and
systemic clinical examination findings were unremarkable.
These clinical signs suggested either focal encephalitis, or a
right-sided space occupying lesion in the right cerebral hemi-
sphere and brainstem. These signs could also be the result of
otitis media, if it were not for the reduced menace response
and facial tremors.
Listerial encephalitiswas initially considered themost likely
differential diagnosis, although there was no supportive his-
tory of recent silage feeding nor any trigeminal or facial nerve
signs. Despite the high flock seroprevalence, visnawas consid-
ered less likely due to this individual’s previous negative serol-
ogy (ID-Vet ELISA [Innovative Diagnostics], approximately
6 months prior), and the relative rarity of the encephalitic
form of this disease in GB. Flavivirus encephalitis (louping ill)
was considered unlikely due to the clinical presentation and
lack of knowledge of ticks on the farm; however, the timing of
presentation could have been consistent with novel exposure
to the virus following the first emergence of ticks since mov-
ing to the farm in thewinter. Central sarcocystosis was consid-
ered as another possible cause of encephalitis, given dogs had
access to the fields and housing, although the clinical signs and
the age of the ewe militated against this possibility.
Treatment
As the diagnosis was unclear from the clinical exam, the
referring veterinary surgeon initiated non-specific empirical
treatment with dexamethasone 0.1 mg/kg intravenous, once
(Dexadreson; MSD); thiamine 10 mg/kg intravenous, once
LEARNING POINTS/TAKE-HOMEMESSAGES
∙ The wide range of clinical signs and insidious
nature of SRLV/maedi-visna may lead to under-
diagnoses.
∙ Visna most commonly presents with myelitis
resulting in a unilateral hind paresis; however, it
may also present with more variable central neu-
rological signs associated with encephalitis.
∙ The sale of lambs from this flock through a large
auctionmart and private sales serves as a reminder
of the importance of biosecurity precautions.
(Vitamin B1; Bimeda); andpenicillin/streptomycin 8/10mg/kg
intramuscular once daily for 7 days (Pen & Strep; Norbrook).
Outcome and follow-up
The ewe was re-examined at the end of the course of treat-
ment, by which point the facial tremors had become more
severe, and there was now left hind paresis and amore general
ataxia (although ataxia can be difficult to assess alongside
paresis). The progression of clinical signs to include signs
referable to the spinal cord led to visna being considered a
more likely diagnosis and a referral visit was arranged for
3 days later.
At the referral visit, the clinical signs were as described pre-
viously, with an additional left-sided facial paresis (dropped
ear, muzzle deviation and absent palpebral reflex), bilateral
facial hyperaesthesia and left-sided hemiparesis (including
increased patellar reflex). The ewe was recumbent, but alert,
and it was decided that euthanasia was required. Blood sam-
ples were taken at the point of euthanasia, and a post-mortem
lumbosacral cerebrospinal fluid (CSF) tap was performed
immediately after.
Nogross abnormalities were seen on inspection of the
brain on post-mortem examination. The CSF was colour-
less, non-turbid and did not form a stable foam on shaking,
suggesting protein levels were normal.18 The CSF leukocyte
concentration was 3.3/µl, which is within the normal range
for ovine CSF (<10/µl).18 Negative pressure within the tho-
rax was present on incision of the diaphragm; however, the
lungs were grossly enlarged with rib impressions and diffuse
congestion. Multifocal < 1 mm diameter firm, grey nodules
were present throughout the lung parenchyma on cut section,
and small volumes of yellowish exudate were present in some
airways. The mammary gland was grossly normal. No joint
distension was noted, although there was a 1-cm semilunar
area of thinning of articular cartilage on lateral aspect of the
right humeral head.
Serology of the blood taken at the time of euthanasia
was positive for antibody against MV using both the ID-
Vet ELISA (Innovative Diagnostics) and the ElitestELISA
(Hyphen Biomed).
Histology of the lungs (Figure 1) showed scattered areas of
mostly perivascular infiltration by lymphocytes, occasionally
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F IGURE  High power section of lung (H&E stain) showing: (a) lymphocytic infiltration; (b) a tertiary lymphoid follicle; and (c) bacterial colonies
F IGURE  Brain, level of rostral lateral ventricle. Extensive leucoencephalitis with rarefaction and loss of neuroparenchymal structure, including myelin,
and gliosis in white matter surrounding lateral ventricle (between arrows) with an area of incipient cavitation (asterisk), accompanied by ependymitis
(arrowheads). There is sparing of deeper white matter (W) and of adjacent grey matter (G). Inset: Lymphofollicular choroid plexitis in adjacent lateral ventricle
forming tertiary lymphoid follicles. In addition, there were
multifocal colonies of bacteria (cocci) in the pulmonary
interstitium and inside alveolar lumens, associated with loss
of structure of adjacent tissue. These histological findings are
consistent with a diagnosis of maedi, with secondary bac-
terial pneumonia, liquefactive necrosis and possible agonal
inhalation. It is interesting to note that the ewe had shown
no clinical signs indicating respiratory disease, despite this
significant pathology.
Histology of the brain (Figure 2) showed severe bilateral
asymmetrical lymphocytic and necrotising leucoencephali-
tis. Perivascular lymphocytic infiltration involved the follow-
ing areas: periventricular white matter (moderate to severe),
fornix (severe), frontal cortex (focal, mild) and brainstem
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(severe, multifocal extensive), accompanied by gliovascu-
lar activation, occasional neuronal chromatolysis and rare
axonal swellings. In addition, in the periventricular cere-
bral white matter and cerebellar peduncles, more severe
changes included extensive predominantly white matter rar-
efaction and incipient cavitation, oedema and infiltration by
macrophages and multinucleated giant cells, extending to
areas of ependymal attenuation and loss. Multifocal lympho-
follicular choroid plexitis was also present. These histological
findings are typical of visna encephalitis.
The combination of serological results and histopathol-
ogy confirm the diagnosis of visna, alongside maedi and
secondary bacterial pneumonia. In light of these findings,
the owner planned to separate seropositive and seronega-
tive animals, in the hope of eventually establishing a sep-
arate MV-accredited flock within the larger holding. How-
ever, this approachmay prove challenging given the increased
number of breakdowns in accredited flocks with non-
accredited stock on the same holding, and the stricter accred-
itation rules for such flocks.19,20 Eighteen months after the
initial diagnosis, the flock management remains unchanged,
and no further serological testing has been performed. In the
intervening period, the owner noted at least two similar
neurological cases (although these were not submitted for
necropsy) and several cases of indurative mastitis.
Despite veterinary advice to the contrary, the owner has
subsequently sold lambs as non-accredited pedigree stock
at a large national auction and in private sales, including to
neighbouring farms. The lambs were not tested by the owner,
and their infection status was unknown at the point of sale,
therefore the owner does not appear to have made any false
claims about their health status. However, there is evidence
of a heritable component to SRLV susceptibility, prenatal and
lactogenic vertical infection and efficient horizontal trans-
mission between lambs.21–23 It is therefore possible that a
significant proportion of these lambs were infected. To date,
the owner has had only one lamb returned by the purchaser
following a positive serology result during post-purchase
quarantine.
DISCUSSION
Visna has been rarely diagnosed in the GB with only three
reports found in the literature.2–4 Where visna has been
reported it has primarily presented with the spinal form (hind
paresis), although the initial signs displayed in this case fit pre-
vious descriptions of the encephalitic form of the disease.4,24
A survey of GB flocks in 2010 found flock level prevalence of
MV to have doubled from 1.4% in 1995/6 to 2.8% (95% CI
1.6–3.9) in 2010; and it was estimated that there were approx-
imately 110,000 infected breeding sheep in GB in 2010.25
Minor annual increases in VIDA submissions were reported
in 2016, but theremay be significant under-reporting given the
insidious nature of the disease.23,25,26 A new national survey
would help assess current within- and between-flock preva-
lence and guide advice regarding the potential impact of the
disease.
Although MV and caprine arthritis and encephalitis were
previously considered to be caused by two separate viruses,
genetic analysis suggests they are both caused by a single SRLV,
albeit with five types (A-E) that show varying degrees of host
species tropism. These types are further divided into subtypes,
with some geographical clustering. Alongside differences in
management and host genetics, this may be partly responsible
for geographical variation in tissue tropism and clinical signs
of MV.7,8 This raises questions about the strain of the virus
present in this imported flock, although genotyping was not
performed in this case.
It is interesting that this ewe was seronegative on the ini-
tial screen 6 months previously. This influenced the initial
differential diagnosis; however, it is not surprising for new
cases to develop over a 6-month period in a flock with a 50%
seroprevalence. Given the timeframe, this ewe may have been
infected horizontally during transit or the housing period,
a known risk factor for the transmission of SRLV within
flocks.26 This would also suggest that clinical signs developed
within 6 months; this relatively rapid progression being more
common in cases of visna than with maedi alone.27 Alterna-
tively, the initial test may have been a false negative or the ewe
may have displayed delayed seroconversion.
Although horizontal transmission is an important route of
infection both within and between flocks, vertical transmis-
sion is known to occur within infected flocks.21 It therefore
seems likely that a proportion of the lambs sold were infected
and may well go on to introduce the disease into previously
uninfected flocks. Of the animals sold from the flock (total
quantity unknown), only one was reportedly returned having
been identified as seropositive on quarantine testing; however,
other infected lambs may have been admitted to flocks if they
had not yet seroconverted or quarantine testing yielded false
negatives. Given these risks, the owner’s decision to sell lambs
as breeding stock is ethically questionable and has placed the
referring veterinary surgeon in a difficult position; particu-
larly given the owner has sold lambs to another client of the
practice. However, the vet is bound by client confidentiality
and can do little more than strongly advise the seller about the
potential risks of the sale and remind all clients about the need
to consider the health status of all bought in animals. This
serves as a stark reminder of the need for good farm biose-
curity, and the need for veterinarians to actively monitor the
SRLV infection status of their clients’ flocks.
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